27 results on '"Marmo R"'
Search Results
2. The interaction of patients' physical status and time to endoscopy on mortality risk in patients with upper gastrointestinal bleeding: A national prospective cohort study.
- Author
-
Bucci C, Marmo C, Soncini M, Riccioni ME, Laursen SB, Gralnek IM, and Marmo R
- Subjects
- Humans, Male, Female, Italy epidemiology, Prospective Studies, Aged, Middle Aged, Logistic Models, Risk Factors, Time Factors, Aged, 80 and over, Health Status, Gastrointestinal Hemorrhage mortality, Length of Stay statistics & numerical data, Endoscopy, Gastrointestinal statistics & numerical data
- Abstract
Background and Aim: The correct time to perform an upper endoscopy is decisive in acutely GI bleeding patients. However, patients' physical status may affect mortality. We speculated that the physical status and procedural time could be the principal factors accountable for death-risk. The primary aim was to verify the interaction between physical status and time to endoscopy on mortality; the secondary aim was to verify the interaction of the physical status and time to endoscopy on the length of stay (LOS)., Methods: Consecutive patients admitted to 50 Italian hospitals were included. Clinical and endoscopic data were recorded. A multiple logistic regression analysis was performed and the interaction of adjusted clinical physical status and time to endoscopy on mortality was calculated., Results: Complete data were available for 3.190 patients. The time frames did not interfere with outcomes but influenced LOS. Conversely, the ASA score correlated with mortality, LOS, need for transfusions and rebleeding risk., Conclusion: Endoscopy time should be tailored to the patient's physical. In our experience, ASA 1-2-3 patients can be safely submitted to endoscopy to reduce the LOS; on the contrary, keen attention should be paid to ASA4 patients, following the 'not too early-not too late' rule (12-24 h from admission)., Competing Interests: Conflicts of Interest None to declare., (Copyright © 2023 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
3. Comparison of assessment tools in acute upper gastrointestinal bleeding: Which one at which time point?
- Author
-
Marmo R, Soncini M, Bucci C, and Zullo A
- Subjects
- Humans, Cohort Studies, Prognosis, Prospective Studies, Risk Assessment methods, ROC Curve, Severity of Illness Index, Gastrointestinal Hemorrhage diagnosis, Hospitalization
- Abstract
Background: Decisions on managing bleeders remain a critical issue due to the high death risk. The Glasgow-Blatchford score (GBS) correctly identifies low-risk patients but none of the existing scores precisely assess the high risk patients., Aims: To evaluate bleeding scores' prognostic performances in predicting mortality risk., Secondary Outcomes: To compare the scores in low and high-risk patients and identify the "best performing cut-off" (if different from the standard one) in discriminating survivors from deceased., Methods: prospective multicenter cohort study including consecutive UGIB patients admitted to 50 Italian hospitals. We collected information to calculate Rockall, PNED, AIMS65, GB, and ABC scores, together with demographic and clinical data, and outcomes., Results: for low-risk patients, the GB and the ABC are the best performing scores; for high-risk patients, all scores showed weak results, with the PNED score having the higher PPV. Searching for the "best performing cut-off", we found different points that determined a relevant numerical gain in terms of patients correctly assessed., Conclusions: we suggest using the GBS and the ABC score at admission, while the PNED appears to be more useful for high-risk. We also suggest using a new decisional cut-offs that, if validated, may increase the accuracy of current scores., Competing Interests: Declaration of Competing Interest None declared., (Copyright © 2022. Published by Elsevier Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
4. Enteroscopy in diagnosis and treatment of small bowel bleeding: A Delphi expert consensus.
- Author
-
Sorge A, Elli L, Rondonotti E, Pennazio M, Spada C, Cadoni S, Cannizzaro R, Calabrese C, de Franchis R, Girelli CM, Marmo R, Riccioni ME, Marmo C, Oliva S, Scarpulla G, Soncini M, Vecchi M, and Tontini GE
- Subjects
- Humans, Consensus, Delphi Technique, Endoscopy, Gastrointestinal, Gastrointestinal Hemorrhage diagnosis, Gastrointestinal Hemorrhage therapy
- Abstract
Background: Enteroscopy plays an important role in the management of small bowel bleeding. However, current guidelines are not specifically designed for small bowel bleeding and recommendations from different international societies do not always align. Consequently, there is heterogeneity in the definitions of clinical entities, clinical practice policies, and adherence to guidelines among clinicians. This represents an obstacle to providing the best patient care and to obtain homogeneous data for clinical research., Aims: The aims of the study were to establish a consensus on the definitions of bleeding entities and on the role of enteroscopy in the management of small bowel bleeding using a Delphi process., Methods: A core group of eight experts in enteroscopy identified five main topics of small bowel bleeding management and drafted statements on each topic. An expert panel of nine gastroenterologists participated in three rounds of the Delphi process, together with the core group., Results: A total of 33 statements were approved after three rounds of Delphi voting., Conclusion: This Delphi consensus proposes clear definitions and a unifying strategy to standardize the management of small bowel bleeding. Furthermore, it provides a useful guide in daily practice for both clinical and technical issues of enteroscopy., Competing Interests: Conflict of Interest Dr. Spada is consultant for Medtronic and Norgine and received grant from AlfaSigma, Pentax, Olympus. Dr.Pennazio received speaker's honoraria from Medtronic and Olympus. Dr. Rondonotti is member of the expert group of Fujifilm, received speaker's honoraria from Fujifilm and consultancy agreement from Medtronic. Dr. Tontini is a consultant for NTC Pharma and F. Hoffmann-La Roche Ltd and received speaker's honoraria from Pentax, Medtronic and NTC Pharma., (Copyright © 2022. Published by Elsevier Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
5. Sustainability in gastroenterology and digestive endoscopy: Position Paper from the Italian Association of Hospital Gastroenterologists and Digestive Endoscopists (AIGO).
- Author
-
Bortoluzzi F, Sorge A, Vassallo R, Montalbano LM, Monica F, La Mura S, Canova D, Checchin D, Fedeli P, Marmo R, and Elli L
- Subjects
- Humans, Endoscopy, Gastrointestinal methods, Italy, Hospitals, Gastroenterology, Gastroenterologists
- Abstract
Climate crisis is dramatically changing life on earth. Environmental sustainability and waste management are rapidly gaining centrality in quality improvement strategies of healthcare, especially in procedure-dominant fields such as gastroenterology and digestive endoscopy. Therefore, healthcare interventions and endoscopic procedures must be evaluated through the 'triple bottom line' of financial, social, and environmental impact. The purpose of the paper is to provide information on the carbon footprint of gastroenterology and digestive endoscopy and outline a set of measures that the sector can take to reduce the emission of greenhouse gases while improving patient outcomes. Scientific societies, hospital executives, single endoscopic units can structure health policies and investment to build a "green endoscopy". The AIGO study group reinforces the role of gastrointestinal endoscopy professionals as advocates of sustainability in digestive endoscopy. The "green endoscopy" can shape a more sustainable health service and lead to an equitable, climate-smart, and healthier future., Competing Interests: Conflict of interest None declared., (Copyright © 2022. Published by Elsevier Ltd.)
- Published
- 2022
- Full Text
- View/download PDF
6. Correct use of telemedicine in gastroenterology, hepatology, and endoscopy during and after the COVID-19 pandemic: Recommendations from the Italian association of hospital gastroenterologists and endoscopists (AIGO).
- Author
-
Costantino A, Bortoluzzi F, Giuffrè M, Vassallo R, Montalbano LM, Monica F, Canova D, Checchin D, Fedeli P, Marmo R, and Elli L
- Subjects
- Celiac Disease therapy, Chronic Disease, Humans, Inflammatory Bowel Diseases therapy, Italy, Liver Diseases therapy, Societies, Medical, COVID-19 prevention & control, Endoscopy, Gastrointestinal, Gastroenterology, SARS-CoV-2, Telemedicine
- Abstract
The purpose of the present document is to provide detailed information on the correct and optimal use of digital media to ensure continuity of care for gastroenterological patients in everyday clinical practice, in health emergencies and/or when the patient cannot reach the hospital for other reasons. During the recent COVID-19 pandemic, telemedicine has allowed many patients with chronic diseases to access remote care worldwide, proving to be the ideal solution to overcome restrictions and carry out non-urgent routine follow-ups on chronic patients. The COVID-19 pandemic has therefore made organizational and cultural renewal essential for the reorganization of healthcare in order to ensure greater continuity of care with a minimum risk of spreading the virus to users, practitioners and their families. These AIGO recommendations are intended to provide Italian gastroenterologists with a tool to use this method appropriately, in compliance with current legislation, in particular the proper approach and procedures for conducting a remote examination using a video conferencing tool, the so-called televisit. In the near future, telemedicine may contribute to a possible reorganization of healthcare systems, through innovative care models focusing on the citizen and facilitating access to services throughout the entire Country., Competing Interests: Conflict of interest The authors declare no conflict of interest, (Copyright © 2021. Published by Elsevier Ltd.)
- Published
- 2021
- Full Text
- View/download PDF
7. The "Hub and Spoke" model has no effect on mortality in acute upper gastrointestinal bleeding: A prospective multicenter cohort study.
- Author
-
Marmo R, Soncini M, Bucci C, and Zullo A
- Subjects
- Aged, Case-Control Studies, Comorbidity, Gastrointestinal Hemorrhage therapy, Humans, Italy epidemiology, Length of Stay statistics & numerical data, Middle Aged, Delivery of Health Care, Integrated organization & administration, Gastrointestinal Hemorrhage mortality
- Abstract
Background: the lack of standardized pathways for patients with gastrointestinal bleeding may have led to differences in their management and inequity to medical care access. The "Hub & Spoke" model was adopted to fill this gap in many disciplines, but, to our knowledge, no data exist on its efficacy on mortality in GI bleeding. We aimed to evaluate if the "Hub & Spoke" organizational model has an impact on mortality risk from UGIB., Methods: from January 2014 to December 2015, 3324 consecutive patients admitted for UGIB in 50 Italian hospitals were enrolled (1977 patients in hospitals within the "Hub & Spoke" network for digestive hemorrhagic emergency and 1347 in hospitals outside the "Hub & Spoke" network). Clinical, endoscopic and organizational data were recorded., Results: we observed no differences in mortality between patients admitted to hospitals included or not included in the "Hub & Spoke" network (5.2% vs 6.1%, p = 0.3). On multivariate analysis, admission in gastroenterology wards (OR 0.61, p = 0.001) or an academic hospital (OR 0.65, p < 0.056) were independent protective factors while being in "Hub & Spoke" organization system did not affect mortality (OR 1.09, p = 0.57)., Conclusion: the "Hub & Spoke" model per sé does not impact on mortality while being treated in academic hospital or gastroenterology wards improved survival., Competing Interests: Declaration of Competing Interest None to declare, (Copyright © 2021 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
8. Reply to: High-dose pre-endoscopic intravenous proton pump inhibitors in upper gastrointestinal bleeding: utility or futility?
- Author
-
Marmo R, Soncini M, Bucci C, and Zullo A
- Subjects
- Administration, Intravenous, Gastrointestinal Hemorrhage chemically induced, Gastrointestinal Hemorrhage drug therapy, Histamine H2 Antagonists therapeutic use, Humans, Medical Futility, Proton Pump Inhibitors therapeutic use
- Abstract
Competing Interests: Declaration of Competing Interest All Authros declare not conflicts of interests
- Published
- 2021
- Full Text
- View/download PDF
9. Pre-endoscopic intravenous proton pump inhibitors therapy for upper gastrointestinal bleeding: A prospective, multicentre study.
- Author
-
Marmo R, Soncini M, Bucci C, and Zullo A
- Subjects
- Aged, Aged, 80 and over, Case-Control Studies, Female, Humans, Italy, Male, Middle Aged, Peptic Ulcer drug therapy, Preoperative Care methods, Prospective Studies, Upper Gastrointestinal Tract, Endoscopy, Gastrointestinal methods, Gastrointestinal Hemorrhage therapy, Proton Pump Inhibitors administration & dosage
- Abstract
Background/aim: The indiscriminate use of high-dose, proton pump inhibitor (PPI) infusion in non-variceal upper gastrointestinal bleeding (UGIB) patients to reduce the rate of peptic ulcers with high-risk stigmata (HRS) has been questioned. We evaluated the prevalence of HRS on peptic ulcer and non-ulcer lesions in patients receiving or not receiving pre-endoscopic PPI therapy., Methods: Data of consecutive UGIB patients observed in 50 Italian centres were analysed. The prevalence of both HRS on peptic ulcers and active bleeding on non-ulcer lesions between patients treated or not treated with PPI were compared. Multivariate analysis was performed., Results: A total of 1,792 (69.8%) out of 2,566 patients received PPI therapy. Prevalence of HRS on ulcers was 51.8% and 53.4% (P = 0.58) in treated and not treated patients, respectively, and the rate of endoscopic therapy did not differ between groups. Prevalence of non-ulcer bleeding lesions was higher in patients treated than in those not treated with PPI (18.7% vs 10.6%; P = 0.023). At multivariate analysis, PPI therapy (OR: 1.16, 95% CI = 0.82-1.64; P = 0.4) was not an independent factor affecting HRS prevalence, which was inversely correlated with timing to endoscopy (OR: 0.85, 95% CI = 0.76-0.95; P = 0.005)., Conclusions: Our data failed to detect a significant role of pre-endoscopic PPI therapy in decreasing prevalence of HRS and need for endoscopic treatment in bleeding patients with either peptic ulcer or non-ulcer lesions., (Copyright © 2020 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
10. Patient's performance status should dictate transfusion strategy in nonvariceal acute upper gastrointestinal bleeding (NV-AUGIB): A prospective multicenter cohort study: Transfusion strategy in NV-AUGIB.
- Author
-
Marmo R, Soncini M, and de Franchis R
- Subjects
- Acute Disease mortality, Aged, Aged, 80 and over, Comorbidity, Erythrocyte Indices, Gastrointestinal Hemorrhage therapy, Humans, Italy, Middle Aged, Prospective Studies, Risk Factors, Severity of Illness Index, Blood Transfusion methods, Gastrointestinal Hemorrhage mortality
- Abstract
Background: Non-variceal acute UGI bleeding (NV-AUGIB) is a frequent indication for transfusion, but the best hemoglobin threshold and target values for transfusion in relation to the patients' performance status are unknown., Objective: To identify threshold and target hemoglobin levels for transfusion favoring survival of patients with NV-AUGIB stratified by ASA score., Design: Prospective cohort study., Setting: 50 hospitals of the Italian National Health Service., Participants: 2758 consecutive patients with NV-AUGIB admitted to 50 Italian hospitals from January 1st, 2014 to December 31st, 2015. Five hemoglobin cut-off values were evaluated., Results: 30-days mortality: overall: 5.4%; ASA 1-2 patients: 2.5%; ASA 3-4 patients: 10.8%. Mortality was higher when hemoglobin at admission was ≤ 7 g/dL in ASA 1-2 patients, and when it was ≤ 8 g/dL in ASA 3-4 patients. The hemoglobin levels after transfusion favouring survival were ≥ 8 g/dL in ASA 1-2, p <0.0001 and 9-10 g/dL in ASA 3-4 patients; p = 0.0002., Conclusions: In patients with NV-AUGIB the physical performance status should dictate the transfusion strategy. In ASA 1-2 patients, admission hemoglobin values ≤ 7 g/dL should prompt transfusion, aiming at a target value of 8-9 g/dL; the corresponding figures for ASA 3-4 patients are: admission hemoglobin level ≤ 8 g/dL and target value of 9-10 g/dL., Competing Interests: Declaration of Competing Interest None, (Copyright © 2020 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
11. Medical care setting is associated with survival in acute upper gastro-intestinal bleeding: A cohort study.
- Author
-
Marmo R, Soncini M, Marmo C, Borbjerg Laursen S, Gralnek IM, and Stanley AJ
- Subjects
- Acute Disease, Aged, Aged, 80 and over, Esophageal and Gastric Varices therapy, Female, Gastroenterology, Gastrointestinal Hemorrhage therapy, Humans, Italy epidemiology, Logistic Models, Male, Middle Aged, Multivariate Analysis, Retrospective Studies, Specialization, Survival Rate trends, Time Factors, Ultrasonography, Endoscopes, Gastrointestinal statistics & numerical data, Esophageal and Gastric Varices mortality, Gastrointestinal Hemorrhage mortality, Inpatients
- Abstract
Background: There are limited data on the effect of the medical care setting on survival in patients admitted with acute upper gastrointestinal bleeding., Aims: To identify the organisational and care setting which provides the optimal survival in patients with acute upper gastrointestinal bleeding., Methods: A retrospective observational study of administrative data from a cohort of patients admitted to a Regional or Local hospital, and cared for in a gastroenterology or general ward., Primary Outcome: 30 day survival for non-variceal bleeding and 42 day survival for variceal bleeding., Results: Out of 3368 patients, the source of bleeding was non-variceal in 2980 (88.5%). Survival, adjusted for clinical and organisational factors, was higher in patients admitted to a gastroenterology ward vs other wards (OR = 2.02 p < 0.0006). Management in a gastroenterology ward in a Regional hospital provided a higher survival rate (95.6% ± 0.08) vs a non-gastroenterology ward in a Local hospital (92.9% ± 0.05 p < 0.01) or a non-gastroenterology ward in a Regional hospital (89.5% ± 0.01 p < 0.0001). Survival (94.0% ± 1.6) in a Local hospital with a gastroenterology ward was significantly higher than in a Regional hospital without (89.5% ± 1.1) p < 0.01., Conclusion: Survival was optimal for patients treated in a gastroenterology ward independently of Regional or Local hospital setting., (Copyright © 2020 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
12. Adherence to European Society of Gastrointestinal Endoscopy recommendations of endoscopists performing small bowel capsule endoscopy in Italy.
- Author
-
Rondonotti E, Spada C, Pennazio M, de Franchis R, Cadoni S, Girelli C, Hassan C, Marmo R, Riccioni ME, Scarpulla G, Soncini M, Vecchi M, and Cannizzaro R
- Subjects
- Capsule Endoscopy methods, Endoscopy, Gastrointestinal methods, Humans, Intestine, Small diagnostic imaging, Italy, Practice Guidelines as Topic, Societies, Medical, Capsule Endoscopy standards, Endoscopy, Gastrointestinal standards, Guideline Adherence statistics & numerical data, Intestinal Diseases diagnostic imaging
- Abstract
Background: The European Society of Gastrointestinal Endoscopy (ESGE) has recently issued a technical review focused on small bowel capsule endoscopy (SBCE)., Aim: To compare SBCE current practice in Italy to ESGE technical recommendations., Material and Methods: A dedicated per-centre semi-quantitative questionnaire was prepared by a group of SBCE experts. One-hundred-fifty Centres were invited to participate in the data collection concerning SBCEs performed between June 2016 and June 2017. Data were compared with ESGE recommendations., Results: 120 Centres participated in the data collection. Current practices agreed with ESGE recommendations in 56.3% (9/16) of the issues evaluated. Differences between ESGE recommendations and current practice concerned the management of patients with pacemakers or cardiac implantable defibrillators (which was in agreement with ESGE recommendations in 31.7% and 15.8% of Centres, respectively), the SBCE setting (only 51% of SBCEs were performed as outpatients procedures), the assessment of capsule excretion (timing and modality were in agreement with ESGE recommendation in 20.0% of Centres), and in the involvement of trained nurses or fellows in training as pre-readers (7/120; 5.8%)., Conclusions: Although SBCE is widely used and largely available in Italy, there are still some technical, practical and organizational issues that can be modified to bridge the gap between current practice and ESGE guideline recommendations., (Copyright © 2018 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
13. Diagnosis of chronic anaemia in gastrointestinal disorders: A guideline by the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) and the Italian Society of Paediatric Gastroenterology Hepatology and Nutrition (SIGENP).
- Author
-
Elli L, Norsa L, Zullo A, Carroccio A, Girelli C, Oliva S, Romano C, Leandro G, Bellini M, Marmo R, Soncini M, Monica F, De Francesco V, Paulon E, Cappellini MD, Motta I, Ferretti F, Orlando S, Mansueto P, Buscarini E, Manfredi G, Agostoni C, Tomba C, and Cannizzaro R
- Subjects
- Adult, Anemia classification, Anemia complications, Anemia, Iron-Deficiency complications, Anemia, Iron-Deficiency diagnosis, Biomarkers, Child, Endoscopy, Gastrointestinal, Humans, Italy, Societies, Medical, Anemia diagnosis, Gastrointestinal Diseases complications
- Abstract
Anaemia is a common pathologic condition, present in almost 5% of the adult population. Iron deficiency is the most common cause; other mechanisms can be involved, making anaemia a multi-factorial disorder in most cases. Anaemia being a frequent manifestation in the diseases of the gastrointestinal tract, patients are often referred to gastroenterologists. Furthermore, upper and lower endoscopy and enteroscopy are pivotal to the diagnostic roadmap of anaemia. In spite of its relevance in the daily clinical practice, there is a limited number of gastroenterological guidelines dedicated to the diagnosis of anaemia. For this reason, the Italian Association of Hospital Gastroenterologists and Endoscopists and the Italian Society of Paediatric Gastroenterology, Hepatology and Nutrition commissioned a panel of experts to prepare a specific guideline on anaemia and its diagnostic roadmap in the gastroenterological scenario. The panel also discussed about the potential involvement of gastroenterologists and endoscopists in the management of patients with anaemia, with particular attention to the correct use of investigations. The panel paid particular attention to practical issues with the aim to support gastroenterologists in their clinical practice when dealing with patients with anaemia., (Copyright © 2019 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
14. Preparation for colonoscopy: Recommendations by an expert panel in Italy.
- Author
-
Spada C, Cannizzaro R, Bianco MA, Conigliaro R, Di Giulio E, Hassan C, Marmo R, Occhipinti P, Radaelli F, Repici A, Ricci E, and Costamagna G
- Subjects
- Administration, Oral, Cathartics adverse effects, Colonic Diseases pathology, Consensus, Drug Administration Schedule, Humans, Italy, Medication Adherence, Patient Education as Topic, Patient Selection, Cathartics administration & dosage, Colon pathology, Colonic Diseases diagnosis, Colonoscopy
- Abstract
Background: Despite several guidelines on bowel preparation being available, their applicability in Italy is poorly investigated., Aims: (1) To create expert-based recommendations for the Italian setting based on available international guidelines on bowel preparation for colonoscopy; (2) to assess consensus across the Italian endoscopy community., Methods: The study was conducted in 2 phases: (a) statements formulation, (b) assessment of consensus. For the first phase, 6 topics related to bowel preparation were identified: (1) efficacy/tolerability; (2) timing; (3) assessment of quality of bowel preparation; (4) factors associated with inadequate preparation; (5) patient education and (6) impact of organisational factors. For each topic, statements were produced and voted by a panel of experts. For consensus assessment, the invited participants were asked to rate the statements. The statement achieved a good level of agreement when at least 70% of voters agreed with it., Results: 25 statements were agreed in the first phase. Agreement was not achieved by the endoscopy community for 7 statements, mainly concerning practical aspects (i.e. strategies for management of patients with inadequate preparation, organisational factors)., Conclusion: A clinically relevant consensus was achieved on the main topics of bowel preparation, such as the choice of laxative and the time of administration, and it may help to homogenize the colonoscopy practice in Italy. Nevertheless, there are a few country-specific preparation-related issues that need to be addressed., (Copyright © 2018 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
15. Quality of bowel cleansing in hospitalized patients undergoing colonoscopy: A multicentre prospective regional study.
- Author
-
Rotondano G, Rispo A, Bottiglieri ME, De Luca L, Lamanda R, Orsini L, Bruzzese D, Galloro G, Romano M, Miranda A, Loguercio C, Esposito P, Nardone G, Compare D, Magno L, Ruggiero S, Imperatore N, De Palma GD, Gennarelli N, Cuomo R, Passananti V, Cirillo M, Cattaneo D, Bozzi RM, D'Angelo V, Marone P, Riccio E, De Nucci C, Monastra S, Caravelli G, Verde C, Di Giorgio P, Giannattasio F, Capece G, Taranto D, De Seta M, Spinosa G, De Stefano S, Familiari V, Cipolletta L, Bianco MA, Sansone S, Galasso G, De Colibus P, Romano M, Borgheresi P, Ricco G, Martorano M, Gravina AG, Marmo R, Rea M, Maurano A, Labianca O, Colantuoni E, Iuliano D, Trovato C, Fontana A, Pasquale L, Morante A, Perugini B, Scaglione G, and Mauro B
- Subjects
- Adult, Aged, Aged, 80 and over, Body Mass Index, Cardiovascular Diseases complications, Chronic Disease, Constipation complications, Diabetes Mellitus, Female, Humans, Male, Middle Aged, Preoperative Care standards, Prospective Studies, Sex Factors, Cathartics administration & dosage, Colonoscopy standards, Inpatients statistics & numerical data, Outpatients statistics & numerical data
- Abstract
Background: Quality of bowel cleansing in hospitalized patients undergoing colonoscopy is often unsatisfactory. No study has investigated the inpatient or outpatient setting as cause of inadequate cleansing., Aims: To assess degree of bowel cleansing in inpatients and outpatients and to identify possible predictors of poor bowel preparation in the two populations., Methods: Prospective multicentre study on consecutive colonoscopies in 25 regional endoscopy units. Univariate and multivariate analysis with odds ratio estimation were performed., Results: Data from 3276 colonoscopies were analyzed (2178 outpatients, 1098 inpatients). Incomplete colonoscopy due to inadequate cleansing was recorded in 369 patients (11.2%). There was no significant difference in bowel cleansing rates between in- and outpatients in both colonic segments. In the overall population, independent predictors of inadequate cleansing both at the level of right and left colon were: male gender (odds ratio, 1.20 [1.02-1.43] and 1.27 [1.05-1.53]), diabetes mellitus (odds ratio, 2.35 [1.68-3.29] and 2.12 [1.47-3.05]), chronic constipation (odds ratio, 1.60 [1.30-1.97] and 1.55 [1.23-1.94]), incomplete purge intake (odds ratio, 2.36 [1.90-2.94] and 2.11 [1.68-2.65]) and a runway time >12h (odds ratio, 3.36 [2.40-4.72] and 2.53 [1.74-3.67])., Conclusions: We found no difference in the rate of inadequate bowel preparation between hospitalized patients and outpatients., (Copyright © 2015 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
16. Prevalence and characteristics of serrated lesions of the colorectum in Italy: A multicentre prospective cohort study.
- Author
-
Rotondano G, Bianco MA, Cipolletta L, and Marmo R
- Subjects
- Adenoma diagnosis, Adult, Aged, Colonoscopy, Colorectal Neoplasms diagnosis, Cross-Sectional Studies, Female, Humans, Intestinal Polyps diagnosis, Italy epidemiology, Male, Middle Aged, Precancerous Conditions diagnosis, Prevalence, Prospective Studies, Risk Factors, Adenoma epidemiology, Colorectal Neoplasms epidemiology, Intestinal Polyps epidemiology, Precancerous Conditions epidemiology
- Abstract
Background: Serrated lesions are recognized as important contributors to colorectal cancer incidence. We aimed to prospectively assess the prevalence of serrated lesions and identify potential predictors of these lesions during colonoscopy in an Italian population., Methods: Prospective cross sectional study involving 8 endoscopy units from February 1st to July 31st 2012., Results: Out of 2468 colonoscopies, 886 precancerous lesions were detected in 567 patients. Of these, 173 SELs were diagnosed in 148 patients (140 serrated/hyperplastic polyps and 33 serrated adenomas). Prevalence was 7% (173/2468). Serrated lesions accounted for 19.5% of all precancerous lesions. Serrated polyps were prevalent in the left colon (42.1%) and serrated adenomas in the proximal colon (54.5%). Independent clinical predictors of serrated lesions were patient age (OR 0.98 [0.97-1.00]) and post-polypectomy surveillance (OR 1.87 [1.24-2.82]). Endoscopic predictors were right colon location (OR 2.65 [1.63-4.30] vs. rectum; and 1.53 [1.03-2.26] vs. left colon), polypoid shape (OR 0.41 [027-0.64]) and size <6 mm (OR 0.49 [0.33-0.72] vs. 6-10 mm; and 0.14 [0.07-0.28] vs. >10 mm). There was no independent predictor of serrated adenoma., Conclusion: In our Italian study population, the prevalence of colorectal serrated lesions was 7%. Their diagnosis is associated with younger age and surveillance colonoscopy, right-sided colorectal location, non-polypoid shape and size <6 mm., (Copyright © 2015 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
17. Predictors of favourable outcome in non-variceal upper gastrointestinal bleeding: implications for early discharge?
- Author
-
Rotondano G, Cipolletta L, Koch M, Bianco MA, Grossi E, and Marmo R
- Subjects
- Age Factors, Aged, Aged, 80 and over, Aspirin therapeutic use, Blood Transfusion statistics & numerical data, Female, Humans, Male, Middle Aged, Multivariate Analysis, Patient Discharge, Platelet Aggregation Inhibitors therapeutic use, Prognosis, Prospective Studies, ROC Curve, Recurrence, Risk Assessment, Treatment Outcome, Endoscopy, Digestive System, Esophageal Diseases therapy, Gastrointestinal Hemorrhage therapy, Hemostasis, Endoscopic, Stomach Diseases therapy
- Abstract
Background: There is a lack of validated predictors on which to decide the timing of discharge in patients already hospitalized for upper nonvariceal bleeding., Aims: Identify factors that appear to protect nonvariceal bleeders from the development of negative outcome (rebleeding, surgery, death)., Methods: Secondary analysis of two prospective multicenter studies. Multivariate analyses for each investigated outcome were performed; a single model was developed including all factors that were statistically significant in each sub-model. A final score was developed to predict favourable outcomes. Prognostic accuracy was tested with ROC curve analysis., Results: Out of 2398 patients, 211 (8.8%) developed one or more adverse outcomes: 87 (3.63%) had rebleeding, 46 (1.92%) needed surgery and 107 (4.46%) died. Predictors of favourable prognosis were: ASA score 1 or 2, absence of neoplasia, outpatient bleeding, use of low-dose aspirin, no need for transfusions, clean-based ulcer, age <70 years, no haemodynamic instability successful endoscopic diagnosis/therapy, no Dieulafoy's lesion at endoscopy, no hematemesis on presentation and no need for endoscopic treatment. Overall prognostic accuracy of the model was 83%. The final score accurately identified 20-30% of patients that eventually do not develop any negative outcome., Conclusions: The "good luck score" may be a useful tool in deciding when to discharge a patient already hospitalized for acute non-variceal bleeding., (Copyright © 2013 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
18. Small bowel obstruction due to penetrating migrated biliary stent: removal with a clip applicator via double balloon enteroscopy.
- Author
-
Marmo R, Rea M, Pecora A, Sansone S, and Rotondano G
- Subjects
- Aged, 80 and over, Device Removal instrumentation, Device Removal methods, Female, Humans, Ileal Diseases diagnostic imaging, Ileal Diseases surgery, Intestinal Obstruction diagnostic imaging, Intestinal Obstruction surgery, Surgical Instruments, Tomography, X-Ray Computed, Cystic Duct, Double-Balloon Enteroscopy methods, Ileal Diseases etiology, Intestinal Obstruction etiology, Prosthesis Failure adverse effects, Stents
- Published
- 2013
- Full Text
- View/download PDF
19. The American Society for Gastrointestinal Endoscopy (ASGE) diagnostic algorithm for obscure gastrointestinal bleeding: eight burning questions from everyday clinical practice.
- Author
-
Rondonotti E, Marmo R, Petracchini M, de Franchis R, and Pennazio M
- Subjects
- Angiography, Capsule Endoscopy, Endoscopy, Gastrointestinal, Humans, Practice Guidelines as Topic, Tomography, X-Ray Computed, Algorithms, Gastrointestinal Hemorrhage diagnosis
- Abstract
The diagnosis and management of patients with obscure gastrointestinal bleeding are often long and challenging processes. Over the last 10 years the introduction in clinical practice of new diagnostic and therapeutic procedures (i.e. Capsule Endoscopy, Computed Tomographic Enterography, Magnetic Resonance Enterography, and Device Assisted Enteroscopy) has revolutionized the diagnostic/therapeutic work-up of these patients. Based on evidence published in the last 10 years, international scientific societies have proposed new practice guidelines for the management of obscure gastrointestinal bleeding, which include these techniques. However, although these algorithms (the most recent ones are endorsed by the American Society for Gastrointestinal Endoscopy - ASGE) allow the management of the large majority of patients, some issues still remain unsolved. The present paper reports the results of the discussion, based on the literature published up to September 2011, among a panel of experts and gastroenterologists, working with Capsule Endoscopy and with Device Assisted Enteroscopy, attending the 6th annual meeting of the Italian Club for Capsule Endoscopy and Enteroscopy. Eight unresolved issues were selected: each of them is presented as a "Burning question" and the "Answer" is the strategy proposed to manage it, according to both the available evidence and the discussion among participants., (Copyright © 2012 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
20. Diagnostic and therapeutic yield of single balloon enteroscopy in patients with suspected small-bowel disease: results of the Italian multicentre study.
- Author
-
Manno M, Riccioni ME, Cannizzaro R, Andreoli A, Marmo R, and Pennazio M
- Subjects
- Adenomatous Polyposis Coli diagnosis, Adenomatous Polyposis Coli surgery, Adult, Aged, Aged, 80 and over, Crohn Disease diagnosis, Duodenal Diseases surgery, Female, Gastrointestinal Hemorrhage diagnosis, Gastrointestinal Hemorrhage surgery, Graft vs Host Disease diagnosis, Humans, Ileal Diseases surgery, Intestinal Neoplasms diagnosis, Intestinal Neoplasms surgery, Italy, Jejunal Diseases surgery, Male, Middle Aged, Prospective Studies, Young Adult, Duodenal Diseases diagnosis, Endoscopy, Gastrointestinal methods, Ileal Diseases diagnosis, Jejunal Diseases diagnosis
- Abstract
Background: Limited data are available on the clinical impact of single balloon enteroscopy., Aims: To evaluate the diagnostic and therapeutic yield of single balloon enteroscopy in patients with suspected small bowel disease., Methods: Data on patients with suspected small bowel disease based on non-invasive imaging, who were subjected sequentially to enteroscopy were prospectively collected., Results: 131 procedures were performed in 111 patients. The mean procedure time was 61±33min for the oral approach, and 78±41min for the anal approach. The mean insertion depth was 223±93cm beyond the ligament of Treitz, and 96±56 beyond the ileo-cecal valve. A diagnosis suspected with prior small bowel tests was confirmed in 82 patients, confidently excluded in 20, while in 9 the suspected area was not reached. Total enteroscopy was deemed clinically unnecessary in 94 patients; when total enteroscopy was attempted, it was achieved in 8 out 17 patients. Endoscopic therapeutic interventions were performed in 39 patients, medical treatment was started in 30, whereas 18 underwent to surgery. No major complications were registered., Conclusions: This study shows that single balloon enteroscopy appears to be an helpful and safe procedure with a high clinical impact, especially when it is placed in decision-making as a third level examination., (Copyright © 2012 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
21. Literature review and recommendations for clinical application of Colon Capsule Endoscopy.
- Author
-
Spada C, Hassan C, Sturniolo GC, Marmo R, Riccioni ME, de Franchis R, Van Gossum A, and Costamagna G
- Subjects
- Capsule Endoscopes, Capsule Endoscopy instrumentation, Capsule Endoscopy methods, Evidence-Based Medicine, Humans, Capsule Endoscopy standards, Cathartics, Colon, Colonic Diseases diagnosis
- Abstract
Colon Capsule Endoscopy represents a new diagnostic technology for colonic exploration. Despite the great enthusiasm around this new technique, only few studies are available in the literature, and reported results are still controversial and non-homogeneous. Current preparation protocols have led to discordant results. In January 2010, the first Italian Meeting on Colon Capsule Endoscopy was held. Aim of this Meeting was to critically evaluate the available results obtained by Colon Capsule Endoscopy in clinical studies, in order to identify the proper test indications, to propose a shared preparation protocol and Colon Capsule Endoscopy procedure. Studies published in literature were extensively reviewed and analysed during the Meeting. The available evidence served to propose recommendations for preparation protocols, proper test indications and Colon Capsule Endoscopy procedure. Possible perspectives were also critically analysed and are reported in this paper., (Copyright © 2010 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
22. Hepatitis B virus infection and immunosuppressive therapy in patients with inflammatory bowel disease.
- Author
-
Morisco F, Castiglione F, Rispo A, Stroffolini T, Vitale R, Sansone S, Granata R, Orlando A, Marmo R, Riegler G, Vecchi M, Biancone L, and Caporaso N
- Subjects
- Hepatitis B, Chronic complications, Hepatitis B, Chronic drug therapy, Hepatitis B, Chronic epidemiology, Hepatitis B, Chronic prevention & control, Humans, Immunosuppression Therapy adverse effects, Immunosuppressive Agents pharmacology, Inflammatory Bowel Diseases complications, Prevalence, Antibiotic Prophylaxis, Antiviral Agents therapeutic use, Hepatitis B, Chronic virology, Immunosuppressive Agents adverse effects, Inflammatory Bowel Diseases drug therapy, Virus Activation drug effects
- Abstract
Hepatitis B reactivation has been widely reported in patients undergoing immunosuppressive therapy in oncohaematological and transplant settings, with a high frequency of hepatic failure. This topic has received growing scientific interest and several studies reported the preventive effect of antiviral agents on hepatitis B reactivation during immunosuppression therapy. Routine prophylaxis is therefore recommended and specific recommendations were elaborated by AASLD, EASL and AISF. On the contrary, few data are available on the risk of HBV reactivation in patients with inflammatory bowel disease (IBD) receiving immunosuppressive therapy, and major questions regarding the optimal management (screening, prophylaxis, therapy, monitoring) of IBD patients with HBV infection remain to be addressed. The aim of this paper is to provide a systematic review of the literature to underline the main aspects of HBV infection and reactivation in patients affected by IBD treated with conventional or biological immunosuppressive drugs., (Copyright © 2011 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
23. Appropriateness of the indication for upper endoscopy: a meta-analysis.
- Author
-
Di Giulio E, Hassan C, Marmo R, Zullo A, and Annibale B
- Subjects
- Adult, Age Factors, False Positive Reactions, Humans, Middle Aged, Practice Guidelines as Topic, ROC Curve, Referral and Consultation, Endoscopy, Gastrointestinal, Esophageal Neoplasms diagnosis, Patient Selection, Stomach Neoplasms diagnosis
- Abstract
Background: Application of appropriate indications for upper endoscopy (EGD) should conserve limited endoscopic resources. To perform a systematic review and meta-analysis to assess the efficacy of American Society for Gastrointestinal Endoscopy and European Panel on the Appropriateness of Gastrointestinal Endoscopy guidelines in selecting patients referred for an upper endoscopy relative to the detection of gastro-oesophageal cancer., Methods: Studies comparing the appropriateness of EGD indication according to American Society for Gastrointestinal Endoscopy or European Panel on the Appropriateness of Gastrointestinal Endoscopy guidelines and the detection of relevant endoscopic findings and cancer were identified by searching the Medline (1982 to September 2008). Pre-defined outputs of the meta-analysis were sensitivity, specificity, and positive and negative likelihood ratios (LR+, LR-)., Results: We included eight cohort studies comprising 13,856 patients; 10,643 EGD indications were categorized as appropriate, and 3010 (22%) as inappropriate. For relevant findings, the adjusted sensitivity, specificity, LR+, and LR- were 85% (95% CI, 84-86%), 28% (95% CI, 27-29%), 1.18 (95% CI, 1.1-1.3) and 0.6 (95% CI, 0.5-0.7), respectively. For cancer detection, the adjusted sensitivity, specificity, LR+, and LR- were 97% (95% CI, 94-98%), 22% (95% CI, 22-23%), 1.2 (95% CI, 1.1-1.4), and 0.2 (95% CI, 0.05-0.9), respectively., Conclusions: For inappropriate EGD, the very low likelihood of cancer argues against endoscopic referral, whereas the low specificity substantially reduces the predictive value of an appropriate indication for both cancer and relevant endoscopic findings., (Copyright (c) 2009 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
24. Acrylate glue injection for acutely bleeding oesophageal varices: A prospective cohort study.
- Author
-
Cipolletta L, Zambelli A, Bianco MA, De Grazia F, Meucci C, Lupinacci G, Salerno R, Piscopo R, Marmo R, Orsini L, and Rotondano G
- Subjects
- Acute Disease, Aged, Esophageal and Gastric Varices complications, Esophageal and Gastric Varices diagnosis, Esophageal and Gastric Varices mortality, Esophagoscopy methods, Female, Gastrointestinal Hemorrhage diagnosis, Gastrointestinal Hemorrhage etiology, Gastrointestinal Hemorrhage mortality, Humans, Injections, Intralesional, Ligation, Male, Middle Aged, Prospective Studies, Recurrence, Treatment Outcome, Cyanoacrylates administration & dosage, Esophageal and Gastric Varices therapy, Gastrointestinal Hemorrhage therapy, Hemostasis, Endoscopic methods, Tissue Adhesives administration & dosage
- Abstract
Background: Acrylate glue injection is seldom performed in patients with bleeding oesophageal varices., Aim: To assess efficacy and safety of acrylate glue injection in patients with bleeding oesophageal varices, as well as the impact of this technique on subsequent variceal ligation., Methods: Prospective study on 133 consecutive cirrhotic patients treated by intravariceal injection of undiluted N-butyl-2-cyanoacrylate into the bleeding varix. Outcome measures were initial haemostasis, recurrent bleeding, complications and mortality at 6 weeks., Results: 52 patients were actively bleeding at endoscopy and 81 showed stigmata of recent haemorrhage. Initial haemostasis was achieved in 49/52 active bleeders (94.2% [95% CI 85.1-98.5]). Overall, early recurrent bleeding occurred in 7 patients (5.2% [95% CI 2.3-10.1]). No major procedure-related complication was recorded. At 6 weeks, death occurred in 11 patients, with an overall bleeding-related mortality of 8.2% [95% CI 5.8-15.3]. Mortality was higher in active (15.4% [95% CI 6.9-28.1]) than non-active bleeders (3.7% [95% CI 0.8-10.4], OR 4.7 [95% CI 1.05-28.7], p=0.02). Of those surviving the first bleeding episode, 112 patients subsequently underwent ligation. No technical difficulties were encountered in performing the banding procedure which was successfully completed in all cases., Conclusions: Emergency injection of acrylate glue is safe and effective for the treatment of acute bleeding oesophageal varices and does not hamper subsequent variceal ligation.
- Published
- 2009
- Full Text
- View/download PDF
25. Endoscopic palliation of malignant obstructive jaundice: an evidence-based review.
- Author
-
Cipolletta L, Rotondano G, Marmo R, and Bianco MA
- Subjects
- Cholangiopancreatography, Endoscopic Retrograde, Cholestasis etiology, Coated Materials, Biocompatible, Costs and Cost Analysis, Humans, Jaundice, Obstructive etiology, Length of Stay, Metals, Plastics, Stents, Cholestasis surgery, Digestive System Neoplasms complications, Jaundice, Obstructive surgery, Palliative Care methods
- Abstract
Endoscopic stent insertion is considered the method of choice for palliative treatment of malignant biliary obstruction. Nonetheless, relevant studies are often underpowered or outdated and do not compare actual surgical outcomes with latest stent technology. Purpose of this review was to assess, with an evidence-based methodology, the role of endoscopic versus surgical palliation of patients with malignant obstructive jaundice with special reference to clinical effectiveness, safety aspects and economic outcomes.
- Published
- 2007
- Full Text
- View/download PDF
26. Long-term outcome of argon plasma coagulation therapy for bleeding caused by chronic radiation proctopathy.
- Author
-
Rotondano G, Bianco MA, Marmo R, Piscopo R, and Cipolletta L
- Subjects
- Adult, Aged, Aged, 80 and over, Argon therapeutic use, Carcinoma radiotherapy, Electrocoagulation adverse effects, Female, Hemoglobins analysis, Humans, Male, Middle Aged, Prostatic Neoplasms radiotherapy, Recurrence, Treatment Outcome, Uterine Cervical Neoplasms radiotherapy, Uterine Neoplasms radiotherapy, Electrocoagulation methods, Gastrointestinal Hemorrhage etiology, Gastrointestinal Hemorrhage surgery, Radiotherapy adverse effects, Rectal Diseases etiology, Rectal Diseases surgery
- Abstract
Background: Radiation-induced proctopathy is a serious complication of radiation therapy for pelvic malignancy., Aim: To assess the safety and efficacy of argon plasma coagulation in the treatment of haemorrhagic radiation-induced proctopathy., Patients: Twenty-four patients with rectal bleeding due to radiation-induced proctopathy were prospectively enrolled in the study., Methods: Indications for treatment were iron deficiency anaemia (n = 16) and persistent bleeding, despite pharmacotherapy (n = 8). Argon flow and power used were 0.8-1.2 l/min and 40 W, respectively. An interval of at least 4 weeks was allowed between treatment sessions. Haemoglobin level, bleeding severity score, number of admissions and transfusion requirements were recorded after endoscopic coagulation and before 12 and 24 months., Results: A median of 2.5 therapeutic sessions per patient were performed (range 1-6). All patients reported clinical improvement and/or cessation of rectal bleeding. The mean value of the bleeding severity score decreased from 2.9 to 0.8 (P < 0.01), while average haemoglobin levels increased by a mean of 1.9 mg/dl at the end of the treatments (P < 0.05). During a minimum follow-up of 24 months (range 24-60), rectal bleeding recurred in two cases and was successfully retreated endoscopically. One patient developed a recto-vaginal fistula., Conclusions: Argon plasma coagulation appears to be a safe and effective technique for management of rectal bleeding caused by radiation-induced proctopathy.
- Published
- 2003
- Full Text
- View/download PDF
27. Interferon-related thyroid autoimmunity and long-term clinical outcome of chronic hepatitis C.
- Author
-
Morisco F, Mazziotti G, Rotondi M, Tuccillo C, Iasevoli P, Del Buono A, Sorvillo F, Amato G, Marmo R, Caporaso N, and Carella C
- Subjects
- Adult, Analysis of Variance, Biopsy, Needle, Disease Progression, Drug Administration Schedule, Enzyme-Linked Immunosorbent Assay, Female, Follow-Up Studies, Hepatitis C Antibodies analysis, Hepatitis C, Chronic diagnosis, Humans, Logistic Models, Male, Middle Aged, Probability, Prospective Studies, Risk Assessment, Sensitivity and Specificity, Severity of Illness Index, Statistics, Nonparametric, Thyroid Function Tests, Thyroiditis, Autoimmune diagnosis, Hepatitis C, Chronic drug therapy, Interferon-alpha administration & dosage, Interferon-alpha adverse effects, Thyroiditis, Autoimmune chemically induced
- Abstract
Background: A high incidence of thyroid autoantibodies and/or disorders was observed in subjects with hepatitis C virus-related chronic hepatitis during interferon-alpha therapy., Aim: To evaluate whether thyroid autoimmunity and dysfunction, induced by interferon-alpha therapy, could be viewed as predictors for treatment response and as valid prognostic markers of liver disease progression., Patients: A total of 136 subjects (96 males/40 females; median age 48 years; range 23-64) affected by biopsy-proven chronic hepatitis C (33.1% with compensated liver cirrhosis)., Methods: All subjects were treated with interferon-alpha therapy at 6 MU 3 times weekly for 12 months and then followed up for an average period of 60 months (range 12-108). Routine laboratory tests, virological assessment, liver ultrasound, thyroid function tests (serum free-triiodothyronine, free-thyroxine, serum thyrotropin), and autoimmunity were performed for all subjects., Results: Percentage of thyroid autoimmunity and thyroid dysfunction in long-term responders was not significantly different compared to that in non-responders (47.0% and 11.8% vs 35.3% and 5.9%, respectively; non significant). The multivariate model demonstrated that the absence of cirrhosis was the only factor significantly related to successful response to therapy (odds ratio: 14.9; 95% confidence interval: 1.9-115.0 for chronic hepatitis C vs presence of cirrhosis). Moreover, the occurrence of thyroid autoimmunity during interferon therapy was similar both in patients with or without worsening of liver disease (33.3% and 39.8%, respectively; p = not significant). No subject with on-going liver disease developed thyroid dysfunction during treatment, as opposed to the 10/118 (8.4%) with a better course of liver disease; however, this difference was not statistically significant. The multivariate model showed that age was the only covariate significantly associated with unfavourable outcome of liver disease (odds ratio: 18.6; 95% confidence interval: 2.3-151.9, for those over 48 years vs younger patients)., Conclusions: There is no evidence that the immune mechanism involved in the pathogenesis of thyroid autoimmune phenomena is the same as that regulating the therapeutic clearance of HCV or modulating the unfavourable course of HCV-related chronic hepatitis. However, our study confirmed that liver disease seems to progress more slowly in younger subjects.
- Published
- 2001
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.